HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Marketing In Brief

This article was originally published in The Rose Sheet

Executive Summary

Nexxus acquisition: Alberto-Culver will acquire the Nexxus Products Company, firm announces May 9, noting it has signed an agreement in principle to purchase substantially all of the assets of the firm related to Nexxus brand hair care products. The acquisition, which is expected to close within 15 days, is not anticipated to have a material impact on the company's short term sales and earnings, firm says. Alberto plans to grow Nexxus brand "substantially" in the future with expanded marketing initiatives and increased human, strategic and financial resources, CEO Howard Bernick reports during a Goldman Sachs Consumer Products Symposium May 11. "I am more excited about the acquisition of Nexxus than any other transaction that we've made since I joined the company 28 years ago," Bernick adds. Net sales for Nexxus Products Company reached approximately $40 mil. in 2004, according to Alberto...

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013050

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel